Inactive Instrument
Compass Biotechnologies, Inc. Stock Other OTC
Stocks
US20452Q1031
Pharmaceuticals
OTC Markets Traded| Market Cap | 806K 693K 652K 595K 1.11M 76.43M 1.12M 7.73M 2.99M 39.07M 3.03M 2.96M 124M | P/E 2018 |
-2.59x | P/E 2019 | -3.95x |
|---|---|---|---|---|---|
| Enterprise Value | 1.29M 1.11M 1.04M 950K 1.77M 122M 1.78M 12.33M 4.77M 62.35M 4.83M 4.72M 198M | EV / Sales 2018 |
-
| EV / Sales 2019 | - |
| Free-Float |
99% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -25.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 2020-04-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Nicole Birch
CHM | Chairman | - | 2020-04-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -25.00% | -.--% | - | - | 8.06K | |
| +0.59% | +0.95% | -14.22% | -3.84% | 13.44B | |
| +0.74% | +1.93% | -30.61% | -55.47% | 4.94B | |
| -0.83% | -1.51% | -4.68% | -3.76% | 4.49B | |
| +0.82% | -0.25% | -3.05% | -28.49% | 3.92B | |
| +0.37% | -1.17% | -22.41% | +5.76% | 3.53B | |
| +0.47% | -0.08% | +0.54% | +1.69% | 3.53B | |
| -0.48% | -0.89% | -11.28% | +7.94% | 3.25B | |
| +0.20% | -0.54% | -22.38% | -14.12% | 2.33B | |
| +1.51% | +0.35% | -26.51% | -13.82% | 1.68B | |
| Average | -2.16% | +0.56% | -14.95% | -11.57% | 4.57B | |
| Weighted average by Cap. | +0.38% | +0.60% | -14.24% | -11.14% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | - | - |
| Net income | -433K -372K -350K -320K -597K -41.05M -600K -4.15M -1.6M -20.98M -1.63M -1.59M -66.48M | -324K -279K -262K -239K -446K -30.7M -449K -3.1M -1.2M -15.69M -1.22M -1.19M -49.72M |
| Net Debt | 516K 444K 417K 381K 711K 48.92M 715K 4.95M 1.91M 25M 1.94M 1.89M 79.22M | 480K 413K 389K 355K 662K 45.54M 665K 4.6M 1.78M 23.28M 1.8M 1.76M 73.75M |
Employees
-
Sector
Pharmaceuticals
